Sterling Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-58,320
Closed -$2.41M 1097
2015
Q2
$2.41M Sell
58,320
-24,950
-30% -$894K 0.02% 265
2015
Q1
$2.93M Buy
83,270
+4,291
+5% +$145K 0.03% 250
2014
Q4
$2.54M Sell
78,979
-3,271
-4% -$94.6K 0.02% 319
2014
Q3
$2.31M Sell
82,250
-2,225
-3% -$67.8K 0.03% 321
2014
Q2
$2.55M Sell
84,475
-6,675
-7% -$184K 0.02% 276
2014
Q1
$2.52M Sell
91,150
-2,440
-3% -$63.8K 0.02% 272
2013
Q4
$2.39M Sell
93,590
-7,040
-7% -$217K 0.02% 241
2013
Q3
$3.01M Sell
100,630
-112,470
-53% -$3.13M 0.04% 181
2013
Q2
$6.13M Buy
+213,100
New +$5.87M 0.08% 144

Other funds holding BRLI

Sterling Capital Management's BRLI Position: Q3 2015 in Review

Sterling Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 58,320 shares — an estimated $2.41M sold.

Sterling Capital Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $6.13M in Q2 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Sterling Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Sterling Capital Management sold 58,320 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.41M.
  • Sterling Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Sterling Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $6.13M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Sterling Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.